[Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer]

Gastroenterol Clin Biol. 2001 Nov;25(11):967-78.
[Article in French]
No abstract available

Publication types

  • Review

MeSH terms

  • Adenomatous Polyposis Coli Protein
  • Apoptosis
  • Colorectal Neoplasms / enzymology
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / prevention & control*
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Cytoskeletal Proteins
  • Gene Expression Regulation, Enzymologic
  • Humans
  • Isoenzymes / antagonists & inhibitors*
  • Isoenzymes / genetics
  • Membrane Proteins
  • Neovascularization, Pathologic
  • Prostaglandin-Endoperoxide Synthases / genetics
  • Trans-Activators*
  • beta Catenin

Substances

  • Adenomatous Polyposis Coli Protein
  • CTNNB1 protein, human
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Cytoskeletal Proteins
  • Isoenzymes
  • Membrane Proteins
  • Trans-Activators
  • beta Catenin
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases